On January 5, 2022 Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, reported that senior leadership plans to present at the following conferences in January (Press release, Genocea Biosciences, JAN 5, 2022, View Source [SID1234598304]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conferences:

Event: Longwood Healthcare Leaders Winter Webconference – Details
Topic 1: Innovation in Cell Therapy
Format: Panel
Date: Thursday, January 6, 2022
Time: 1:30 PM ET
Topic 2: Making a Big Impact With Limited Resources
Format:
Date:
Time: Panel
Thursday, January 6, 2022
5:10 PM ET

Event:

LifeSci Partners 11th Annual Corporate Access Event – Details
Topic 1: Innovative Approaches to Cell Therapy for Oncology
Format: Panel
Date: Friday, January 7, 2022
Time: 8:30 AM ET
Topic 2: Cancer Vaccines: Promises, Promises … Has Their Day Come?
Format:
Date:
Time: Panel
Friday, January 7, 2022
2:00 PM ET

Event: H.C. Wainwright BIOCONNECT Virtual Conference – Details
Topic: Corporate Update
Format: On demand presentation
Date: Monday, January 10, 2022
Time: 7:00 AM ET

Event: Advanced Therapies Week – Details
Topic: Add It Up: 3 Things to Consider for Capacity Expansion
Format: Panel
Date: Wednesday, January 26, 2022
Time: 5:00 PM ET